Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers in Young Girls.

Trial Profile

Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers in Young Girls.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 02 May 2017

At a glance

  • Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
  • Indications Cervical cancer; Genital warts; Human papillomavirus infections
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 06 Feb 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Nov 2013 to 1 Jun 2014.
    • 07 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 02 Apr 2013 Planned End Date changed from 1 Jan 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top